Safety and Effectiveness of Varenicline in a Veteran Population with a High Prevalence of Mental Illness

BACKGROUND: Varenicline is a selective nicotinic receptor partial agonist used to aid in the process of smoking cessation. Research on varenicline's approval for marketing demonstrated that after 12 weeks of treatment, at least 44% of patients successfully quit smoking and, on average, 13% of indivi... View More